Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in J Virol

Retrieve available abstracts of 443 articles:
HTML format

Single Articles

    July 2024
  1. SPACKMAN E, Jones DR, McCoig AM, Colonius TJ, et al
    Characterization of highly pathogenic avian influenza virus in retail dairy products in the US.
    J Virol. 2024 Jul 3:e0088124. doi: 10.1128/jvi.00881.
    PubMed     Abstract available

    June 2024
  2. YU X, Tian J, Wang Y, Su N, et al
    The pseudogene GBP1P1 suppresses influenza A virus replication by acting as a protein decoy for DHX9.
    J Virol. 2024 Jun 28:e0073824. doi: 10.1128/jvi.00738.
    PubMed     Abstract available

  3. DAVID SC, Schaub A, Terrettaz C, Motos G, et al
    Stability of influenza A virus in droplets and aerosols is heightened by the presence of commensal respiratory bacteria.
    J Virol. 2024 Jun 13:e0040924. doi: 10.1128/jvi.00409.
    PubMed     Abstract available

    May 2024
  4. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    Correction for Huang et al., "N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies".
    J Virol. 2024 May 31:e0112823. doi: 10.1128/jvi.01128.

  5. CARTER DM, Darby CA, Lefoley BC, Crevar CJ, et al
    Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses".
    J Virol. 2024 May 31:e0181323. doi: 10.1128/jvi.01813.

  6. CARTER DM, Darby CA, Johnson SK, Carlock MA, et al
    Retraction for Carter et al., "Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses".
    J Virol. 2024 May 31:e0183223. doi: 10.1128/jvi.01832.

  7. MARIZZI C, Ajayi PK, McMahon R, Meade PS, et al
    A community science approach to public health and public trust in science.
    J Virol. 2024 May 29:e0082524. doi: 10.1128/jvi.00825.
    PubMed     Abstract available

  8. KNOLL M, Honce R, Meliopoulos V, Segredo-Otero EA, et al
    Host obesity impacts genetic variation in influenza A viral populations.
    J Virol. 2024 May 24:e0177823. doi: 10.1128/jvi.01778.
    PubMed     Abstract available

  9. SCHWAB LSU, Do THT, Pilapitiya D, Koutsakos M, et al
    Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
    J Virol. 2024 May 23:e0160423. doi: 10.1128/jvi.01604.
    PubMed     Abstract available

  10. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    PubMed     Abstract available

  11. MEADE PS, Bandawane P, Bushfield K, Hoxie I, et al
    Detection of clade highly pathogenic H5N1 influenza virus in New York City.
    J Virol. 2024 May 15:e0062624. doi: 10.1128/jvi.00626.
    PubMed     Abstract available

  12. CESAR RAMOS DE JESUS H, Solis N, Machado Y, Pablos I, et al
    Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL(pro) main protease (Mpro) from proteomic identification of P6-P6' active site specificity.
    J Virol. 2024 May 14:e0004924. doi: 10.1128/jvi.00049.
    PubMed     Abstract available

  13. YU M, Li J, Gao W, Li Z, et al
    Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    J Virol. 2024 May 6:e0162423. doi: 10.1128/jvi.01624.
    PubMed     Abstract available

    April 2024
  14. VIOX EG, Bosinger SE, Douek DC, Schreiber G, et al
    Harnessing the power of IFN for therapeutic approaches to COVID-19.
    J Virol. 2024 Apr 23:e0120423. doi: 10.1128/jvi.01204.
    PubMed     Abstract available

  15. MAO D, Liu S, Phan AT, Renner S, et al
    The TRAF3-DYRK1A-RAD54L2 complex maintains ACE2 expression to promote SARS-CoV-2 infection.
    J Virol. 2024 Apr 23:e0034724. doi: 10.1128/jvi.00347.
    PubMed     Abstract available

  16. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    PubMed     Abstract available

  17. BOUGON J, Kadijk E, Gallot-Lavallee L, Curtis BA, et al
    Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff in infected cells.
    J Virol. 2024 Apr 17:e0190123. doi: 10.1128/jvi.01901.
    PubMed     Abstract available

  18. PEREZ DR
    A devastating blow: personal reflections on Argentina's scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    PubMed     Abstract available

  19. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    PubMed     Abstract available

  20. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    PubMed     Abstract available

  21. BU H, Zhang S, Li P, Liu Z, et al
    Secreted phospholipase PLA2G2E contributes to regulation of T cell immune response against influenza virus infection.
    J Virol. 2024 Apr 9:e0019824. doi: 10.1128/jvi.00198.
    PubMed     Abstract available

  22. BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
    Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
    PubMed     Abstract available

  23. YANG R, Han P, Han P, Li D, et al
    Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
    PubMed     Abstract available

  24. XIAO X, Fu Y, You W, Huang C, et al
    Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
    J Virol. 2024 Apr 4:e0157323. doi: 10.1128/jvi.01573.
    PubMed     Abstract available

  25. MAES A, Botzki A, Mathys J, Impens F, et al
    Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza A virus infection.
    J Virol. 2024 Apr 3:e0185723. doi: 10.1128/jvi.01857.
    PubMed     Abstract available

  26. SILVA F, Boal-Carvalho I, Williams N, Chabert M, et al
    Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3.
    J Virol. 2024 Apr 3:e0041124. doi: 10.1128/jvi.00411.
    PubMed     Abstract available

  27. KEOWN J, Baazaoui A, Sebesta M, Stefl R, et al
    Structural and functional characterization of the interaction between the influenza A virus RNA polymerase and the CTD of host RNA polymerase II.
    J Virol. 2024 Apr 2:e0013824. doi: 10.1128/jvi.00138.
    PubMed     Abstract available

  28. BRUNET J, Choucha Z, Gransagne M, Tabbal H, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
    J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
    PubMed     Abstract available

  29. NAMBULLI S, Escriou N, Rennick LJ, Demers MJ, et al
    A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.
    J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
    PubMed     Abstract available

    March 2024
  30. MAI F, Bergmann W, Reisinger EC, Muller-Hilke B, et al
    The varying extent of humoral and cellular immune responses to either vector- or RNA-based SARS-CoV-2 vaccines persists for at least 18 months and is independent of infection.
    J Virol. 2024 Mar 19:e0191223. doi: 10.1128/jvi.01912.
    PubMed     Abstract available

  31. BABOT M, Boulard Y, Agouda S, Pieri L, et al
    Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
    J Virol. 2024 Mar 14:e0157523. doi: 10.1128/jvi.01575.
    PubMed     Abstract available

  32. SPRUIT CM, Palme DI, Li T, Rios Carrasco M, et al
    Complex N-glycans are important for interspecies transmission of H7 influenza A viruses.
    J Virol. 2024 Mar 12:e0194123. doi: 10.1128/jvi.01941.
    PubMed     Abstract available

  33. HEINDL MR, Rupp A-L, Schwerdtner M, Bestle D, et al
    ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells.
    J Virol. 2024 Mar 12:e0010224. doi: 10.1128/jvi.00102.
    PubMed     Abstract available

  34. WEN F, Yan Z, Chen G, Chen Y, et al
    Recent H9N2 avian influenza virus lost hemagglutination activity due to a K141N substitution in hemagglutinin.
    J Virol. 2024 Mar 11:e0024824. doi: 10.1128/jvi.00248.
    PubMed     Abstract available

  35. ZHENG T, Shen B, Bai Y, Li E, et al
    The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
    J Virol. 2024 Mar 6:e0156523. doi: 10.1128/jvi.01565.
    PubMed     Abstract available

    February 2024
  36. ZHANG M, Liu M, Chen H, Qiu T, et al
    PB2 residue 473 contributes to the mammalian virulence of H7N9 avian influenza virus by modulating viral polymerase activity via ANP32A.
    J Virol. 2024 Feb 29:e0194423. doi: 10.1128/jvi.01944.
    PubMed     Abstract available

  37. MARTINS M, Nooruzzaman M, Cunningham JL, Ye C, et al
    The SARS-CoV-2 Spike is a virulence determinant and plays a major role on the attenuated phenotype of Omicron virus in a feline model of infection.
    J Virol. 2024 Feb 29:e0190223. doi: 10.1128/jvi.01902.
    PubMed     Abstract available

  38. HAN J, Chang W, Fang J, Hou X, et al
    The H9N2 avian influenza virus increases APEC adhesion to oviduct epithelia by viral NS1 protein-mediated activation of the TGF-beta pathway.
    J Virol. 2024 Feb 28:e0151223. doi: 10.1128/jvi.01512.
    PubMed     Abstract available

  39. UPRETY T, Yu J, Nogales A, Naveed A, et al
    Influenza D virus utilizes both 9-O-acetylated N-acetylneuraminic and 9-O-acetylated N-glycolylneuraminic acids as functional entry receptors.
    J Virol. 2024 Feb 20:e0004224. doi: 10.1128/jvi.00042.
    PubMed     Abstract available

  40. NIE L, Huang Y, Cheng Z, Luo H, et al
    An intranasal influenza virus vector vaccine protects against Helicobacter pylori in mice.
    J Virol. 2024 Feb 15:e0192323. doi: 10.1128/jvi.01923.
    PubMed     Abstract available

  41. ZENG J, Du F, Xiao L, Sun H, et al
    Spatiotemporal genotype replacement of H5N8 avian influenza viruses contributed to H5N1 emergence in 2021/2022 panzootic.
    J Virol. 2024 Feb 15:e0140123. doi: 10.1128/jvi.01401.
    PubMed     Abstract available

  42. THOMAS MN, Zanella GC, Cowan B, Caceres CJ, et al
    Nucleoprotein reassortment enhanced transmissibility of H3 1990.4.a clade influenza A virus in swine.
    J Virol. 2024 Feb 14:e0170323. doi: 10.1128/jvi.01703.
    PubMed     Abstract available

  43. KATAYAMA M, Murakami S, Ishida H, Matsugo H, et al
    Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein among influenza D virus lineages revealed using epitope mapping.
    J Virol. 2024 Feb 12:e0190823. doi: 10.1128/jvi.01908.
    PubMed     Abstract available

  44. VANSLAMBROUCK JM, Neil JA, Rudraraju R, Mah S, et al
    Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
    J Virol. 2024 Feb 9:e0180223. doi: 10.1128/jvi.01802.
    PubMed     Abstract available

  45. SHINGAI M, Iida S, Kawai N, Kawahara M, et al
    Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire.
    J Virol. 2024 Feb 7:e0199523. doi: 10.1128/jvi.01995.
    PubMed     Abstract available

  46. YANG Q, Barbachano-Guerrero A, Fairchild LM, Rowland TJ, et al
    Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses.
    J Virol. 2024 Feb 7:e0156323. doi: 10.1128/jvi.01563.
    PubMed     Abstract available

  47. LI H, Sun H, Tao M, Han Q, et al
    Recombinant parainfluenza virus 5 expressing clade H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
    J Virol. 2024 Feb 2:e0112923. doi: 10.1128/jvi.01129.
    PubMed     Abstract available

  48. NIU S, Zhao Z, Liu Z, Rong X, et al
    Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
    J Virol. 2024 Feb 2:e0115723. doi: 10.1128/jvi.01157.
    PubMed     Abstract available

  49. BRICKER TL, Joshi A, Soudani N, Scheaffer SM, et al
    Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.
    J Virol. 2024 Feb 2:e0120623. doi: 10.1128/jvi.01206.
    PubMed     Abstract available

  50. HSIEH M-S, Hsu C-W, Liao H-C, Lin C-L, et al
    SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
    J Virol. 2024 Feb 1:e0154623. doi: 10.1128/jvi.01546.
    PubMed     Abstract available

    January 2024
  51. ROWE T, Davis W, Wentworth DE, Ross T, et al
    Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
    J Virol. 2024 Jan 31:e0149423. doi: 10.1128/jvi.01494.
    PubMed     Abstract available

  52. SHEN S, Guo H, Li Y, Zhang L, et al
    SARS-CoV-2 and oncolytic EV-D68-encoded proteases differentially regulate pyroptosis.
    J Virol. 2024 Jan 30:e0190923. doi: 10.1128/jvi.01909.
    PubMed     Abstract available

  53. KIERAN TJ, Sun X, Maines TR, Beauchemin CAA, et al
    Exploring associations between viral titer measurements and disease outcomes in ferrets inoculated with 125 contemporary influenza A viruses.
    J Virol. 2024 Jan 19:e0166123. doi: 10.1128/jvi.01661.
    PubMed     Abstract available

  54. DULIN H, Barre RS, Xu D, Neal A, et al
    Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2.
    J Virol. 2024 Jan 11:e0157123. doi: 10.1128/jvi.01571.
    PubMed     Abstract available

  55. HE Y, Guo Z, Subiaur S, Benegal A, et al
    Antibody inhibition of influenza A virus assembly and release.
    J Virol. 2024 Jan 5:e0139823. doi: 10.1128/jvi.01398.
    PubMed     Abstract available

  56. DEY S, Mondal A
    Unveiling the role of host kinases at different steps of influenza A virus life cycle.
    J Virol. 2024 Jan 4:e0119223. doi: 10.1128/jvi.01192.
    PubMed     Abstract available

  57. FARJO M, Koelle K, Martin MA, Gibson LL, et al
    Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection.
    J Virol. 2024 Jan 4:e0161823. doi: 10.1128/jvi.01618.
    PubMed     Abstract available

  58. LI K, Verma A, Li P, Ortiz ME, et al
    Adaptation of SARS-CoV-2 to ACE2(H353K) mice reveals new spike residues that drive mouse infection.
    J Virol. 2024 Jan 3:e0151023. doi: 10.1128/jvi.01510.
    PubMed     Abstract available

  59. RASMUSSEN AL, Gronvall GK, Lowen AC, Goodrum F, et al
    Virology-the path forward.
    J Virol. 2024 Jan 3:e0179123. doi: 10.1128/jvi.01791.
    PubMed     Abstract available

    December 2023
  60. BOLLAND W, Michel V, Planas D, Hubert M, et al
    High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.
    J Virol. 2023 Dec 13:e0135123. doi: 10.1128/jvi.01351.
    PubMed     Abstract available

  61. JERONIMO PMC, Aksenen CF, Duarte IO, Lins RD, et al
    Evolutionary deletions within the SARS-CoV-2 genome as signature trends for virus fitness and adaptation.
    J Virol. 2023 Dec 13:e0140423. doi: 10.1128/jvi.01404.
    PubMed     Abstract available

  62. ZHANG L, Shao Y, Wang Y, Yang Q, et al
    Twenty natural amino acid substitution screening at the last residue 121 of influenza A virus NS2 protein reveals the critical role of NS2 in promoting virus genome replication by coordinating with viral polymerase.
    J Virol. 2023 Dec 6:e0116623. doi: 10.1128/jvi.01166.
    PubMed     Abstract available

  63. PHAM TX, Huynh TTX, Choi J, Lee J-B, et al
    SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
    J Virol. 2023 Dec 5:e0173723. doi: 10.1128/jvi.01737.
    PubMed     Abstract available

  64. ZAYOU L, Prakash S, Dhanushkodi NR, Quadiri A, et al
    A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4(+) and CD8(+) T cells and enhanced protection against COVID-19-like symptoms and death caused by SARS-CoV-2 infection.
    J Virol. 2023 Dec 1:e0109623. doi: 10.1128/jvi.01096.
    PubMed     Abstract available

    November 2023
  65. LI K, Huntwork RHC, Horn GQ, Abraha M, et al
    Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.
    J Virol. 2023 Nov 29:e0107023. doi: 10.1128/jvi.01070.
    PubMed     Abstract available

  66. DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
    Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.
    J Virol. 2023 Nov 21:e0151123. doi: 10.1128/jvi.01511.
    PubMed     Abstract available

  67. BRAGAZZI CUNHA J, Leix K, Sherman EJ, Mirabelli C, et al
    Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection.
    J Virol. 2023 Nov 17:e0127623. doi: 10.1128/jvi.01276.
    PubMed     Abstract available

  68. ALRUWAILI M, Armstrong S, Prince T, Erdmann M, et al
    SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption.
    J Virol. 2023 Nov 6:e0042423. doi: 10.1128/jvi.00424.
    PubMed     Abstract available

  69. SUN W, Xu J, Wang Z, Li D, et al
    Clade H5 chimeric cold-adapted attenuated influenza vaccines induced cross-reactive protection in mice and ferrets.
    J Virol. 2023 Nov 2:e0110123. doi: 10.1128/jvi.01101.
    PubMed     Abstract available

  70. RIJNINK WF, Stadlbauer D, Puente-Massaguer E, Okba NMA, et al
    Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses.
    J Virol. 2023 Nov 2:e0164622. doi: 10.1128/jvi.01646.
    PubMed     Abstract available

    October 2023
  71. PAHMEIER F, Lavacca T-M, Goellner S, Neufeldt CJ, et al
    Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis.
    J Virol. 2023 Oct 31:e0087823. doi: 10.1128/jvi.00878.
    PubMed     Abstract available

  72. CAO J, Shi M, Zhu L, Li X, et al
    The matrix protein of respiratory syncytial virus suppresses interferon signaling via RACK1 association.
    J Virol. 2023;97:e0074723.
    PubMed     Abstract available

  73. BARTSCH YC, Cizmeci D, Yuan D, Mehta N, et al
    Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
    J Virol. 2023 Oct 30:e0077123. doi: 10.1128/jvi.00771.
    PubMed     Abstract available

  74. LI Y, Arcos S, Sabsay KR, Te Velthuis AJW, et al
    Deep mutational scanning reveals the functional constraints and evolutionary potential of the influenza A virus PB1 protein.
    J Virol. 2023 Oct 26:e0132923. doi: 10.1128/jvi.01329.
    PubMed     Abstract available

  75. YAN Z, Li Y, Huang S, Wen F, et al
    Global distribution, receptor binding, and cross-species transmission of H6 influenza viruses: risks and implications for humans.
    J Virol. 2023 Oct 25:e0137023. doi: 10.1128/jvi.01370.
    PubMed     Abstract available

  76. UNDI RB, Ahsan N, Larabee JL, Darlene-Reuter N, et al
    Blocking of doublecortin-like kinase 1-regulated SARS-CoV-2 replication cycle restores cell signaling network.
    J Virol. 2023 Oct 20:e0119423. doi: 10.1128/jvi.01194.
    PubMed     Abstract available

  77. KUMAR S, Delipan R, Chakraborty D, Kanjo K, et al
    Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity.
    J Virol. 2023 Oct 20:e0092223. doi: 10.1128/jvi.00922.
    PubMed     Abstract available

  78. YE G, Pan R, Bu F, Zheng J, et al
    Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19.
    J Virol. 2023 Oct 19:e0144823. doi: 10.1128/jvi.01448.
    PubMed     Abstract available

  79. SUN H, Wang Y, Chen X, Jiang Y, et al
    Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant.
    J Virol. 2023 Oct 19:e0113723. doi: 10.1128/jvi.01137.
    PubMed     Abstract available

  80. JOHNSON RM, Ardanuy J, Hammond H, Logue J, et al
    Diet-induced obesity and diabetes enhance mortality and reduce vaccine efficacy for SARS-CoV-2.
    J Virol. 2023 Oct 17:e0133623. doi: 10.1128/jvi.01336.
    PubMed     Abstract available

  81. LIANG CY, Huang I, Han J, Sownthirarajan B, et al
    Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells.
    J Virol. 2023 Oct 16:e0090623. doi: 10.1128/jvi.00906.
    PubMed     Abstract available

  82. WU Y, Shi J, He X, Lu J, et al
    Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants.
    J Virol. 2023 Oct 16:e0127923. doi: 10.1128/jvi.01279.
    PubMed     Abstract available

  83. MISPLON JA, Lo CY, Crabbs TA, Price GE, et al
    Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccination.
    J Virol. 2023 Oct 13:e0067423. doi: 10.1128/jvi.00674.
    PubMed     Abstract available

  84. MIURA K, Suzuki Y, Ishida K, Arakawa M, et al
    Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells.
    J Virol. 2023 Oct 13:e0042623. doi: 10.1128/jvi.00426.
    PubMed     Abstract available

  85. MAHE D, Bourgeau S, da Silva J, Schlederer J, et al
    SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo.
    J Virol. 2023 Oct 13:e0110423. doi: 10.1128/jvi.01104.
    PubMed     Abstract available

  86. RIBO-MOLINA P, Weiss HJ, Susma B, van Nieuwkoop S, et al
    4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1.
    J Virol. 2023 Oct 12:e0132523. doi: 10.1128/jvi.01325.
    PubMed     Abstract available

  87. ISELI AN, Pohl MO, Glas I, Gaggioli E, et al
    The neuraminidase activity of influenza A virus determines the strain-specific sensitivity to neutralization by respiratory mucus.
    J Virol. 2023 Oct 11:e0127123. doi: 10.1128/jvi.01271.
    PubMed     Abstract available

  88. GIRARD J, Jakob C, Toews LK, Fuchs J, et al
    Disruption of influenza virus packaging signals results in various misassembled genome complexes.
    J Virol. 2023 Oct 9:e0107623. doi: 10.1128/jvi.01076.
    PubMed     Abstract available

  89. CARNACCINI S, Caceres CJ, Gay LC, Ferreri LM, et al
    Antigenic mapping of the hemagglutinin of the H9 subtype influenza A viruses using sera from Japanese quail (Coturnix c. japonica).
    J Virol. 2023 Oct 6:e0074323. doi: 10.1128/jvi.00743.
    PubMed     Abstract available

  90. MCMAHON M, Tan J, O'Dell G, Kirkpatrick Roubidoux E, et al
    Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner.
    J Virol. 2023 Oct 6:e0105723. doi: 10.1128/jvi.01057.
    PubMed     Abstract available

  91. KIMURA I, Yamasoba D, Nasser H, Ito H, et al
    Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
    J Virol. 2023 Oct 5:e0101123. doi: 10.1128/jvi.01011.
    PubMed     Abstract available

  92. MENG X, Veit M
    Palmitoylation of the hemagglutinin of influenza B virus by ER-localized DHHC enzymes 1, 2, 4, and 6 is required for efficient virus replication.
    J Virol. 2023 Oct 4:e0124523. doi: 10.1128/jvi.01245.
    PubMed     Abstract available

    September 2023
  93. ZHAO Y, Sui L, Wu P, Li L, et al
    EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8.
    J Virol. 2023 Sep 29:e0102823. doi: 10.1128/jvi.01028.
    PubMed     Abstract available

  94. LI J, Gui Q, Liang FX, Sall J, et al
    The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication.
    J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507.
    PubMed     Abstract available

  95. NENNA R, Stern DA, Carr TF, Spangenberg A, et al
    Prenatal exposure to RSV season influences first-year risk of RSV lower respiratory illness and RSV-specific immune responses assessed at birth.
    J Virol. 2023;97:e0076723.
    PubMed     Abstract available

  96. WALLACE LE, de Vries E, van Kuppeveld FJM, de Haan CAM, et al
    Neuraminidase-dependent entry of influenza A virus is determined by hemagglutinin receptor-binding specificity.
    J Virol. 2023 Sep 27:e0060223. doi: 10.1128/jvi.00602.
    PubMed     Abstract available

  97. MCCOOL RS, Musayev M, Bush SM, Derrien-Colemyn A, et al
    Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope.
    J Virol. 2023 Sep 22:e0092923. doi: 10.1128/jvi.00929.
    PubMed     Abstract available

  98. SCHOEN A, Holzer M, Muller MA, Wallerang KB, et al
    Functional comparisons of the virus sensor RIG-I from humans, the microbat Myotis daubentonii, and the megabat Rousettus aegyptiacus, and their response to SARS-CoV-2 infection.
    J Virol. 2023 Sep 20:e0020523. doi: 10.1128/jvi.00205.
    PubMed     Abstract available

  99. FUJITA S, Kosugi Y, Kimura I, Tokunaga K, et al
    Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to Rhinolophus bat ACE2.
    J Virol. 2023 Sep 19:e0099023. doi: 10.1128/jvi.00990.
    PubMed     Abstract available

  100. XING M, Wang Y, Wang X, Liu J, et al
    Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants.
    J Virol. 2023 Sep 14:e0072423. doi: 10.1128/jvi.00724.
    PubMed     Abstract available

  101. CASE JB, Scheaffer SM, Darling TL, Bricker TL, et al
    Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
    J Virol. 2023 Sep 7:e0062823. doi: 10.1128/jvi.00628.
    PubMed     Abstract available

    August 2023
  102. LIN HF, Liu MQ, Jiang RD, Gong QC, et al
    Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
    J Virol. 2023 Aug 21:e0079023. doi: 10.1128/jvi.00790.
    PubMed     Abstract available

  103. LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
    A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases.
    J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
    PubMed     Abstract available

  104. JIN H, Cheng L, Gong Y, Zhu Y, et al
    Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
    J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
    PubMed     Abstract available

  105. ZHANG W, Shi K, Geng Q, Herbst M, et al
    Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
    J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
    PubMed     Abstract available

  106. LLEWELLYN GN, Chen HY, Rogers GL, Huang X, et al
    Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides.
    J Virol. 2023 Aug 9:e0068423. doi: 10.1128/jvi.00684.
    PubMed     Abstract available

  107. MYKYTYN AZ, Breugem TI, Geurts MH, Beumer J, et al
    SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models.
    J Virol. 2023 Aug 9:e0085123. doi: 10.1128/jvi.00851.
    PubMed     Abstract available

  108. THOMPSON D, Cismaru CV, Rougier JS, Schwemmle M, et al
    The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins.
    J Virol. 2023 Aug 4:e0038823. doi: 10.1128/jvi.00388.
    PubMed     Abstract available

    July 2023
  109. TALUKDAR SN, McGregor B, Osan JK, Hur J, et al
    Respiratory Syncytial Virus Infection Does Not Induce Epithelial-Mesenchymal Transition.
    J Virol. 2023;97:e0039423.
    PubMed     Abstract available

  110. HICKERSON BT, Petrovskaya SN, Dickensheets H, Donnelly RP, et al
    Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility.
    J Virol. 2023 Jul 5:e0015423. doi: 10.1128/jvi.00154.
    PubMed     Abstract available

  111. JENSEN JL, Sankhala RS, Dussupt V, Bai H, et al
    Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
    J Virol. 2023 Jul 3:e0159622. doi: 10.1128/jvi.01596.
    PubMed     Abstract available

    June 2023
  112. HUANG J, Chen Z, Ye Y, Shao Y, et al
    DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.
    J Virol. 2023;97:e0068723.
    PubMed     Abstract available

  113. YANG X, Duan H, Liu X, Zhang X, et al
    Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
    J Virol. 2023 Jun 27:e0061023. doi: 10.1128/jvi.00610.
    PubMed     Abstract available

  114. TERASAKI K, Narayanan K, Makino S
    Identification of a 1.4-kb-Long Sequence Located in the nsp12 and nsp13 Coding Regions of SARS-CoV-2 Genomic RNA That Mediates Efficient Viral RNA Packaging.
    J Virol. 2023 Jun 27:e0065923. doi: 10.1128/jvi.00659.
    PubMed     Abstract available

  115. LI A, Zhang B, Zhao K, Yin Z, et al
    SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
    J Virol. 2023 Jun 22:e0051223. doi: 10.1128/jvi.00512.
    PubMed     Abstract available

  116. GOFFIN E, Du X, Hemmi S, Machiels B, et al
    A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
    J Virol. 2023 Jun 20:e0013523. doi: 10.1128/jvi.00135.
    PubMed     Abstract available

  117. CHEN P, Jin Z, Peng L, Zheng Z, et al
    Characterization of an Emergent Chicken H3N8 Influenza Virus in Southern China: a Potential Threat to Public Health.
    J Virol. 2023 Jun 8:e0043423. doi: 10.1128/jvi.00434.
    PubMed     Abstract available

  118. ZHENG H, Ma L, Gui R, Lin X, et al
    Correction for Zheng et al., "G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2".
    J Virol. 2023 Jun 6:e0054623. doi: 10.1128/jvi.00546.

    May 2023
  119. WANG C, Honce R, Salvatore M, Chow D, et al
    Influenza Defective Interfering Virus Promotes Multiciliated Cell Differentiation and Reduces the Inflammatory Response in Mice.
    J Virol. 2023 May 31:e0049323. doi: 10.1128/jvi.00493.
    PubMed     Abstract available

  120. RUNSTADLER JA, Lowen AC, Kayali G, Tompkins SM, et al
    Field Research Is Essential to Counter Virological Threats.
    J Virol. 2023;97:e0054423.
    PubMed     Abstract available

  121. REZENDE W, Ye X, Angelo LS, Carisey AF, et al
    The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent.
    J Virol. 2023;97:e0025423.
    PubMed     Abstract available

  122. SREENIVASAN CC, Liu R, Gao R, Guo Y, et al
    Influenza C and D Viruses Demonstrated a Differential Respiratory Tissue Tropism in a Comparative Pathogenesis Study in Guinea Pigs.
    J Virol. 2023 May 18:e0035623. doi: 10.1128/jvi.00356.
    PubMed     Abstract available

  123. JIANG H, Joshi A, Gan T, Janowski AB, et al
    The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
    J Virol. 2023 May 18:e0063523. doi: 10.1128/jvi.00635.
    PubMed     Abstract available

  124. SLANINA H, Madhugiri R, Wenk K, Reinke T, et al
    Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.
    J Virol. 2023 May 18:e0046523. doi: 10.1128/jvi.00465.
    PubMed     Abstract available

  125. ISHIMARU H, Nishimura M, Tjan LH, Sutandhio S, et al
    Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
    J Virol. 2023 May 16:e0028623. doi: 10.1128/jvi.00286.
    PubMed     Abstract available

  126. ZHANG L, Wang Y, Shao Y, Guo J, et al
    Fine Regulation of Influenza Virus RNA Transcription and Replication by Stoichiometric Changes in Viral NS1 and NS2 Proteins.
    J Virol. 2023 May 11:e0033723. doi: 10.1128/jvi.00337.
    PubMed     Abstract available

  127. SENGAR A, Cervantes M, Bondalapati ST, Hess T, et al
    Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry.
    J Virol. 2023 May 3:e0199222. doi: 10.1128/jvi.01992.
    PubMed     Abstract available

    April 2023
  128. SPECK P, Mackenzie J, Bull RA, Slobedman B, et al
    Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse".
    J Virol. 2023 Apr 25:e0045123. doi: 10.1128/jvi.00451.

  129. PEACOCK TP, Sheppard CM, Lister MG, Staller E, et al
    Mammalian ANP32A and ANP32B Proteins Drive Differential Polymerase Adaptations in Avian Influenza Virus.
    J Virol. 2023 Apr 19:e0021323. doi: 10.1128/jvi.00213.
    PubMed     Abstract available

  130. KETTUNEN P, Lesnikova A, Rasanen N, Ojha R, et al
    SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
    J Virol. 2023 Apr 11:e0014423. doi: 10.1128/jvi.00144.
    PubMed     Abstract available

  131. LIN SJ, Lin KM, Chen SJ, Ku CC, et al
    Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression.
    J Virol. 2023 Apr 6:e0010223. doi: 10.1128/jvi.00102.
    PubMed     Abstract available

    March 2023
  132. TAN Y, Shilts MH, Rosas-Salazar C, Puri V, et al
    Influence of Sex on Respiratory Syncytial Virus Genotype Infection Frequency and Nasopharyngeal Microbiome.
    J Virol. 2023;97:e0147222.
    PubMed     Abstract available

  133. ALWINE JC, Casadevall A, Enquist LW, Goodrum FD, et al
    A critical analysis of the evidence for the SARS-CoV-2 origin hypotheses.
    J Virol. 2023 Mar 10:e0036523. doi: 10.1128/jvi.00365.
    PubMed     Abstract available

  134. WANG X, Wang W, Wang T, Wang J, et al
    SARS-CoV-2 ORF8 Protein Induces Endoplasmic Reticulum Stress-like Responses and Facilitates Virus Replication by Triggering Calnexin: an Unbiased Study.
    J Virol. 2023 Mar 6:e0001123. doi: 10.1128/jvi.00011.
    PubMed     Abstract available

  135. MOLS VC, Lamers MM, Leijten LM, Breugem TI, et al
    Intestinal Tropism of a Betacoronavirus (Merbecovirus) in Nathusius's Pipistrelle Bat (Pipistrellus nathusii), Its Natural Host.
    J Virol. 2023 Mar 1:e0009923. doi: 10.1128/jvi.00099.
    PubMed     Abstract available

    February 2023
  136. FROLOV I, Agback T, Palchevska O, Dominguez F, et al
    All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein.
    J Virol. 2023 Feb 27:e0186522. doi: 10.1128/jvi.01865.
    PubMed     Abstract available

  137. ZHANG L, Hom N, Ojha A, Lovendahl KN, et al
    Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions.
    J Virol. 2023 Feb 15:e0165022. doi: 10.1128/jvi.01650.
    PubMed     Abstract available

  138. CHIEN YA, Alford BK, Wasik BR, Weichert WS, et al
    Single Particle Analysis of H3N2 Influenza Entry Differentiates the Impact of the Sialic Acids (Neu5Ac and Neu5Gc) on Virus Binding and Membrane Fusion.
    J Virol. 2023 Feb 13:e0146322. doi: 10.1128/jvi.01463.
    PubMed     Abstract available

  139. WANG X, Wen Z, Cao H, Luo J, et al
    Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.
    J Virol. 2023 Feb 13:e0161122. doi: 10.1128/jvi.01611.
    PubMed     Abstract available

  140. WANG Y, Ge F, Wang J, Li H, et al
    Mycobacterium bovis BCG Given at Birth Followed by Inactivated Respiratory Syncytial Virus Vaccine Prevents Vaccine-Enhanced Disease by Promoting Trained Macrophages and Resident Memory T Cells.
    J Virol. 2023 Feb 13:e0176422. doi: 10.1128/jvi.01764.
    PubMed     Abstract available

  141. AMANAT F, Clark J, Carreno JM, Strohmeier S, et al
    Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
    J Virol. 2023 Feb 13:e0166422. doi: 10.1128/jvi.01664.
    PubMed     Abstract available

  142. WAN Z, Zhao Z, Sang J, Jiang W, et al
    Amino Acid Variation at Hemagglutinin Position 193 Impacts the Properties of H9N2 Avian Influenza Virus.
    J Virol. 2023 Feb 7:e0137922. doi: 10.1128/jvi.01379.
    PubMed     Abstract available

  143. BEI C, Zhang C, Wu H, Feng H, et al
    DDX3X Is Hijacked by Snakehead Vesiculovirus Phosphoprotein To Facilitate Virus Replication via Stabilization of the Phosphoprotein.
    J Virol. 2023 Feb 6:e0003523. doi: 10.1128/jvi.00035.
    PubMed     Abstract available

  144. SCHINDEWOLF C, Lokugamage K, Vu MN, Johnson BA, et al
    SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
    J Virol. 2023 Feb 1:e0153222. doi: 10.1128/jvi.01532.
    PubMed     Abstract available

    January 2023
  145. TJARNHAGE E, Brown D, Bogen B, Andersen TK, et al
    Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza.
    J Virol. 2023 Jan 31:e0169422. doi: 10.1128/jvi.01694.
    PubMed     Abstract available

  146. GOODRUM F, Lowen A, Lakdawala S, Alwine J, et al
    Virology under the Microscope-a Call for Rational Discourse.
    J Virol. 2023 Jan 26:e0008923. doi: 10.1128/jvi.00089.
    PubMed     Abstract available

  147. GAUDINO M, Lion A, Sagne E, Nagamine B, et al
    The Activation of the RIG-I/MDA5 Signaling Pathway upon Influenza D Virus Infection Impairs the Pulmonary Proinflammatory Response Triggered by Mycoplasma bovis Superinfection.
    J Virol. 2023 Jan 24:e0142322. doi: 10.1128/jvi.01423.
    PubMed     Abstract available

  148. LIU MQ, Lin HF, Li J, Chen Y, et al
    A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice.
    J Virol. 2023 Jan 23:e0171922. doi: 10.1128/jvi.01719.
    PubMed     Abstract available

  149. RAJAGOPALA SV, Strickland BA, Pakala SB, Kimura KS, et al
    Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    J Virol. 2023 Jan 19:e0147822. doi: 10.1128/jvi.01478.
    PubMed     Abstract available

  150. MA J, Liu X, Zhou M, Chen P, et al
    A Heterologous Challenge Rescues the Attenuated Immunogenicity of SARS-CoV-2 Omicron BA.1 Variant in Syrian Hamster Model.
    J Virol. 2023 Jan 18:e0168422. doi: 10.1128/jvi.01684.
    PubMed     Abstract available

  151. SHIWA-SUDO N, Sakai Y, Iwata-Yoshikawa N, Watanabe S, et al
    Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    J Virol. 2023 Jan 12:e0136622. doi: 10.1128/jvi.01366.
    PubMed     Abstract available

  152. CREAGER HM, Kieran TJ, Zeng H, Sun X, et al
    Utility of Human In Vitro Data in Risk Assessments of Influenza A Virus Using the Ferret Model.
    J Virol. 2023 Jan 5:e0153622. doi: 10.1128/jvi.01536.
    PubMed     Abstract available

  153. MCGINNES CULLEN L, Luo B, Wen Z, Zhang L, et al
    The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.
    J Virol. 2023 Jan 5:e0190022. doi: 10.1128/jvi.01900.
    PubMed     Abstract available

    December 2022
  154. CHANG P, Lukosaityte D, Sealy JE, Rijal P, et al
    Antigenic Characterization of Human Monoclonal Antibodies for Therapeutic Use against H7N9 Avian Influenza Virus.
    J Virol. 2022 Dec 21:e0143122. doi: 10.1128/jvi.01431.
    PubMed     Abstract available

  155. GOUMA S, Furey C, Santos JJS, Parkhouse K, et al
    Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation.
    J Virol. 2022 Dec 19:e0172322. doi: 10.1128/jvi.01723.
    PubMed     Abstract available

  156. MEADE P, Strohmeier S, Bermudez-Gonzalez MC, Garcia-Sastre A, et al
    Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity.
    J Virol. 2022 Dec 19:e0107022. doi: 10.1128/jvi.01070.
    PubMed     Abstract available

  157. CHEN LF, Xu WB, Xiong S, Cai JX, et al
    PIK-24 Inhibits RSV-Induced Syncytium Formation via Direct Interaction with the p85alpha Subunit of PI3K.
    J Virol. 2022;96:e0145322.
    PubMed     Abstract available

  158. VALIENTE L, Lopez-Arguello S, Rodriguez-Huete A, Valbuena A, et al
    Molecular Determinants of Human Rhinovirus Infection, Assembly, and Conformational Stability at Capsid Protein Interfaces.
    J Virol. 2022;96:e0084022.
    PubMed     Abstract available

  159. CHEN Y, Wu Y, Chen S, Zhan Q, et al
    Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein.
    J Virol. 2022 Dec 5:e0124522. doi: 10.1128/jvi.01245.
    PubMed     Abstract available

    November 2022
  160. BELSER JA, Sun X, Kieran TJ, Brock N, et al
    Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
    J Virol. 2022 Nov 30:e0140322. doi: 10.1128/jvi.01403.
    PubMed     Abstract available

  161. CHOI SSA, Chan HH, Chan CM, Wang X, et al
    Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry.
    J Virol. 2022 Nov 30:e0141822. doi: 10.1128/jvi.01418.
    PubMed     Abstract available

  162. LI J, Xue L, Wang J, Meng A, et al
    Activation of the Chemokine Receptor CCR1 and Preferential Recruitment of Galphai Suppress RSV Replication: Implications for Developing Novel Respiratory Syncytial Virus Treatment Strategies.
    J Virol. 2022;96:e0130922.
    PubMed     Abstract available

  163. STEPHENS LM, Ross KA, McLellan JS, Narasimhan B, et al
    Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model.
    J Virol. 2022;96:e0150222.
    PubMed     Abstract available

  164. LISTA MJ, Winstone H, Wilson HD, Dyer A, et al
    The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.
    J Virol. 2022 Nov 9:e0125022. doi: 10.1128/jvi.01250.
    PubMed     Abstract available

  165. JAMES J, Bhat S, Walsh SK, Karunarathna TK, et al
    The Origin of Internal Genes Contributes to the Replication and Transmission Fitness of H7N9 Avian Influenza Virus.
    J Virol. 2022 Nov 7:e0129022. doi: 10.1128/jvi.01290.
    PubMed     Abstract available

  166. WANG X, Kerkmann L, Hetzel M, Windmann S, et al
    Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
    J Virol. 2022 Nov 7:e0113322. doi: 10.1128/jvi.01133.
    PubMed     Abstract available

  167. CZERKIES M, Kochanczyk M, Korwek Z, Prus W, et al
    Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    J Virol. 2022 Nov 3:e0134122. doi: 10.1128/jvi.01341.
    PubMed     Abstract available

  168. MO JS, Abente EJ, Cardenas Perez M, Sutton TC, et al
    Transmission of Human Influenza A Virus in Pigs Selects for Adaptive Mutations on the HA Gene.
    J Virol. 2022 Nov 1:e0148022. doi: 10.1128/jvi.01480.
    PubMed     Abstract available

    October 2022
  169. SACCO MT, Bland KM, Horner SM
    WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
    J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
    PubMed     Abstract available

  170. GUO K, Yombo DJK, Schmit T, Wang Z, et al
    Cellular Heterogeneity and Molecular Reprogramming of the Host Response during Influenza Acute Lung Injury.
    J Virol. 2022 Oct 26:e0124622. doi: 10.1128/jvi.01246.
    PubMed     Abstract available

  171. PENN R, Tregoning JS, Flight KE, Baillon L, et al
    Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model.
    J Virol. 2022 Oct 13:e0117822. doi: 10.1128/jvi.01178.
    PubMed     Abstract available

  172. VAN ROYEN T, Sedeyn K, Moschonas GD, Toussaint W, et al
    An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25.
    J Virol. 2022;96:e0129722.
    PubMed     Abstract available

  173. TAN TS, Toyoda M, Ode H, Barabona G, et al
    Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike.
    J Virol. 2022 Oct 10:e0116222. doi: 10.1128/jvi.01162.
    PubMed     Abstract available

  174. BONIFACIO JPPL, Williams N, Garnier L, Hugues S, et al
    Optimizing the Live Attenuated Influenza A Vaccine Backbone for High-Risk Patient Groups.
    J Virol. 2022 Oct 3:e0087122. doi: 10.1128/jvi.00871.
    PubMed     Abstract available

    September 2022
  175. CHEN M, Wang MH, Shen XG, Liu H, et al
    Neuropilin-1 Facilitates Pseudorabies Virus Replication and Viral Glycoprotein B Promotes Its Degradation in a Furin-Dependent Manner.
    J Virol. 2022 Sep 29:e0131822. doi: 10.1128/jvi.01318.
    PubMed     Abstract available

  176. BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
    Correction for Bimler et al., "Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A".
    J Virol. 2022 Sep 27:e0135822. doi: 10.1128/jvi.01358.

  177. GUAN M, Olivier AK, Lu X, Epperson W, et al
    The Sialyl Lewis X Glycan Receptor Facilitates Infection of Subtype H7 Avian Influenza A Viruses.
    J Virol. 2022 Sep 20:e0134422. doi: 10.1128/jvi.01344.
    PubMed     Abstract available

  178. GELLENONCOURT S, Saunders N, Robinot R, Auguste L, et al
    The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
    J Virol. 2022 Sep 19:e0130122. doi: 10.1128/jvi.01301.
    PubMed     Abstract available

  179. SIA ZR, Chiem K, Huang WC, Seffouh A, et al
    Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.
    J Virol. 2022 Sep 15:e0100622. doi: 10.1128/jvi.01006.
    PubMed     Abstract available

  180. CALIENDO V, Leijten L, van de Bildt MWG, Poen MJ, et al
    Long-Term Protective Effect of Serial Infections with H5N8 Highly Pathogenic Avian Influenza Virus in Wild Ducks.
    J Virol. 2022 Sep 13:e0123322. doi: 10.1128/jvi.01233.
    PubMed     Abstract available

  181. BEDI S, Mudgal R, Haag A, Ono A, et al
    A Glu-Glu-Tyr Sequence in the Cytoplasmic Tail of the M2 Protein Renders Influenza A Virus Susceptible to Restriction of the Hemagglutinin-M2 Association in Primary Human Macrophages.
    J Virol. 2022 Sep 13:e0071622. doi: 10.1128/jvi.00716.
    PubMed     Abstract available

  182. AO Z, Ouyang MJ, Olukitibi TA, Warner B, et al
    A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    J Virol. 2022 Sep 7:e0133722. doi: 10.1128/jvi.01337.
    PubMed     Abstract available

  183. EVSEEV D, Miranzo-Navarro D, Fleming-Canepa X, Webster RG, et al
    Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.
    J Virol. 2022 Sep 7:e0077622. doi: 10.1128/jvi.00776.
    PubMed     Abstract available

    August 2022
  184. ZHANG C, Cui H, Guo Z, Chen Z, et al
    SARS-CoV-2 Virus Culture, Genomic and Subgenomic RNA Load, and Rapid Antigen Test in Experimentally Infected Syrian Hamsters.
    J Virol. 2022 Aug 30:e0103422. doi: 10.1128/jvi.01034.
    PubMed     Abstract available

  185. SHEN W, Wang Q, Wang Z, Liu M, et al
    Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
    J Virol. 2022 Aug 29:e0123822. doi: 10.1128/jvi.01238.
    PubMed     Abstract available

  186. FAN B, Peng Q, Song S, Shi D, et al
    Nonstructural Protein 1 of Variant PEDV Plays a Key Role in Escaping Replication Restriction by Complement C3.
    J Virol. 2022 Aug 29:e0102422. doi: 10.1128/jvi.01024.
    PubMed     Abstract available

  187. MARTINS M, do Nascimento GM, Nooruzzaman M, Yuan F, et al
    The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    J Virol. 2022 Aug 24:e0096122. doi: 10.1128/jvi.00961.
    PubMed     Abstract available

  188. SU C, He J, Han P, Bai B, et al
    Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
    J Virol. 2022 Aug 24:e0081422. doi: 10.1128/jvi.00814.
    PubMed     Abstract available

  189. KAZEMI S, Lopez-Munoz AD, Holly J, Jin L, et al
    Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs.
    J Virol. 2022 Aug 24:e0025622. doi: 10.1128/jvi.00256.
    PubMed     Abstract available

  190. JIAO Z, Yan Y, Chen Y, Wang G, et al
    Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
    J Virol. 2022 Aug 24:e0090722. doi: 10.1128/jvi.00907.
    PubMed     Abstract available

  191. NEERUKONDA SN, Wang R, Vassell R, Baha H, et al
    Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    J Virol. 2022 Aug 24:e0114022. doi: 10.1128/jvi.01140.
    PubMed     Abstract available

  192. BLAUROCK C, Pfaff F, Scheibner D, Hoffmann B, et al
    Evidence for Different Virulence Determinants and Host Response after Infection of Turkeys and Chickens with Highly Pathogenic H7N1 Avian Influenza Virus.
    J Virol. 2022 Aug 22:e0099422. doi: 10.1128/jvi.00994.
    PubMed     Abstract available

  193. ZHOU Y, Zheng R, Liu D, Liu S, et al
    UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    J Virol. 2022 Aug 18:e0074122. doi: 10.1128/jvi.00741.
    PubMed     Abstract available

  194. GUPTA SL, Mantus G, Manning KE, Ellis M, et al
    Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults.
    J Virol. 2022 Aug 17:e0058222. doi: 10.1128/jvi.00582.
    PubMed     Abstract available

  195. HAN Y, Bai X, Liu S, Zhu J, et al
    XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.
    J Virol. 2022 Aug 16:e0077422. doi: 10.1128/jvi.00774.
    PubMed     Abstract available

  196. SHI J, Zheng J, Tai W, Verma AK, et al
    A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 16:e0011822. doi: 10.1128/jvi.00118.
    PubMed     Abstract available

  197. FARRUKEE R, Gunalan V, Maurer-Stroh S, Reading PC, et al
    Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    J Virol. 2022;96:e0091822.
    PubMed     Abstract available

  198. UNDI RB, Larabee JL, Filiberti A, Ulahannan S, et al
    Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19.
    J Virol. 2022 Aug 9:e0096722. doi: 10.1128/jvi.00967.
    PubMed     Abstract available

  199. CHAN M, Tiwary M, Wu HL, Tailor N, et al
    Pandemic 1918 Influenza Virus Does Not Cause Lethal Infection in Rhesus or Cynomolgus Macaques.
    J Virol. 2022 Aug 4:e0072822. doi: 10.1128/jvi.00728.
    PubMed     Abstract available

  200. ABDELNABI R, Foo CS, Kaptein SJF, Boudewijns R, et al
    A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection.
    J Virol. 2022 Aug 4:e0075822. doi: 10.1128/jvi.00758.
    PubMed     Abstract available

  201. ZHAN W, Tian X, Zhang X, Xing S, et al
    Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    J Virol. 2022 Aug 4:e0048022. doi: 10.1128/jvi.00480.
    PubMed     Abstract available

  202. ABBADI N, Nagashima K, Pena-Briseno A, Ross TM, et al
    Differential Recognition of Computationally Optimized H3 Hemagglutinin Influenza Vaccine Candidates by Human Antibodies.
    J Virol. 2022 Aug 2:e0089622. doi: 10.1128/jvi.00896.
    PubMed     Abstract available

  203. SCHWAB LSU, Londrigan SL, Brooks AG, Hurt AC, et al
    Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets.
    J Virol. 2022 Aug 2:e0055922. doi: 10.1128/jvi.00559.
    PubMed     Abstract available

  204. XU C, Zhang N, Yang Y, Liang W, et al
    Immune Escape Adaptive Mutations in Hemagglutinin Are Responsible for the Antigenic Drift of Eurasian Avian-Like H1N1 Swine Influenza Viruses.
    J Virol. 2022 Aug 2:e0097122. doi: 10.1128/jvi.00971.
    PubMed     Abstract available

  205. LI Z, Fang P, Duan P, Chen J, et al
    Porcine Deltacoronavirus Infection Cleaves HDAC2 to Attenuate Its Antiviral Activity.
    J Virol. 2022 Aug 2:e0102722. doi: 10.1128/jvi.01027.
    PubMed     Abstract available

  206. YUAN M, Chen X, Zhu Y, Dong X, et al
    A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
    J Virol. 2022 Aug 2:e0077522. doi: 10.1128/jvi.00775.
    PubMed     Abstract available

    July 2022
  207. FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
    Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
    PubMed     Abstract available

  208. HUI X, Cao L, Xu T, Zhao L, et al
    PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication.
    J Virol. 2022 Jul 21:e0078622. doi: 10.1128/jvi.00786.
    PubMed     Abstract available

  209. AKAISHI T, Horii A, Ishii T
    Sequence Exchange Involving Dozens of Consecutive Bases with External Origin in SARS-Related Coronaviruses.
    J Virol. 2022 Jul 20:e0100222. doi: 10.1128/jvi.01002.

  210. GUO H, Li A, Lin HF, Liu MQ, et al
    The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
    J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
    PubMed     Abstract available

  211. KAMIKI H, Murakami S, Nishikaze T, Hiono T, et al
    Influenza A Virus Agnostic Receptor Tropism Revealed Using a Novel Biological System with Terminal Sialic Acid Knockout Cells.
    J Virol. 2022 Jul 18:e0041622. doi: 10.1128/jvi.00416.
    PubMed     Abstract available

  212. BEACH SS, Hull MA, Ytreberg FM, Patel JS, et al
    Molecular Modeling Predicts Novel Antibody Escape Mutations in the Respiratory Syncytial Virus Fusion Glycoprotein.
    J Virol. 2022;96:e0035322.
    PubMed     Abstract available

  213. MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
    Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
    J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
    PubMed     Abstract available

  214. CHAPARIAN RR, Harding AT, Hamele CE, Riebe K, et al
    A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    J Virol. 2022 Jul 12:e0068922. doi: 10.1128/jvi.00689.
    PubMed     Abstract available

  215. OISHI K, Horiuchi S, Minkoff JM, tenOever BR, et al
    The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    J Virol. 2022 Jul 12:e0076522. doi: 10.1128/jvi.00765.
    PubMed     Abstract available

  216. PUSNIK J, Konig J, Mai K, Richter E, et al
    Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
    PubMed     Abstract available

  217. VAN DE VEN K, van Dijken H, Du W, de Heij F, et al
    Varying Viral Replication and Disease Profiles of H2N2 Influenza in Ferrets Is Associated with Virus Isolate and Inoculation Route.
    J Virol. 2022 Jul 11:e0073222. doi: 10.1128/jvi.00732.
    PubMed     Abstract available

  218. YOUK S, Leyson C, Killian ML, Torchetti MK, et al
    Evolution of the North American Lineage H7 Avian Influenza Viruses in Association with H7 Virus's Introduction to Poultry.
    J Virol. 2022 Jul 7:e0027822. doi: 10.1128/jvi.00278.
    PubMed     Abstract available

  219. HAMELE CE, Russell AB, Heaton NS
    In Vivo Profiling of Individual Multiciliated Cells during Acute Influenza A Virus Infection.
    J Virol. 2022 Jul 6:e0050522. doi: 10.1128/jvi.00505.
    PubMed     Abstract available

    June 2022
  220. VAN OOSTEN L, Yan K, Rawle DJ, Le TT, et al
    An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice.
    J Virol. 2022 Jun 29:e0084422. doi: 10.1128/jvi.00844.

  221. JIANG C, Li L, Xue M, Zhao L, et al
    Long-Term Expanding Porcine Airway Organoids Provide Insights into the Pathogenesis and Innate Immunity of Porcine Respiratory Coronavirus Infection.
    J Virol. 2022 Jun 28:e0073822. doi: 10.1128/jvi.00738.
    PubMed     Abstract available

  222. DIEBOLD O, Gonzalez V, Venditti L, Sharp C, et al
    Using Species a Rotavirus Reverse Genetics to Engineer Chimeric Viruses Expressing SARS-CoV-2 Spike Epitopes.
    J Virol. 2022 Jun 27:e0048822. doi: 10.1128/jvi.00488.
    PubMed     Abstract available

  223. BI W, Chen G, Dang B
    Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
    J Virol. 2022 Jun 23:e0068122. doi: 10.1128/jvi.00681.
    PubMed     Abstract available

  224. CHAN CE, Ng CG, Lim AP, Seah SL, et al
    The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
    J Virol. 2022 Jun 21:e0045522. doi: 10.1128/jvi.00455.
    PubMed     Abstract available

  225. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    PubMed     Abstract available

  226. SUN C, Yuan RY, Xie C, Sun JF, et al
    Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.
    J Virol. 2022 Jun 14:e0038322. doi: 10.1128/jvi.00383.
    PubMed     Abstract available

  227. LAVIE M, Dubuisson J, Belouzard S
    SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
    J Virol. 2022 Jun 9:e0047422. doi: 10.1128/jvi.00474.
    PubMed     Abstract available

  228. CHRISTENSEN SR, Martin ET, Petrie JG, Monto AS, et al
    The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade.
    J Virol. 2022;96:e0220021.
    PubMed     Abstract available

  229. SEVENICH M, van den Heuvel J, Gering I, Mohrluder J, et al
    A So-Far Overlooked Secondary Conformation State in the Binding Mode of SARS-CoV-2 Spike Protein to Human ACE2 and Its Conversion Rate Are Crucial for Estimating Infectivity Efficacy of the Underlying Virus Variant.
    J Virol. 2022 Jun 8:e0068522. doi: 10.1128/jvi.00685.
    PubMed     Abstract available

  230. SCHEIBNER D, Breithaupt A, Luttermann C, Blaurock C, et al
    Genetic Determinants for Virulence and Transmission of the Panzootic Avian Influenza Virus H5N8 Clade in Pekin Ducks.
    J Virol. 2022 Jun 7:e0014922. doi: 10.1128/jvi.00149.
    PubMed     Abstract available

  231. CHEN X, Li J, Yang L, Zhou Y, et al
    Immunoglobin G Sero-Dynamics Aided Host Specific Linear Epitope Identification and Differentiation of Infected from Vaccinated Hosts.
    J Virol. 2022 Jun 6:e0014322. doi: 10.1128/jvi.00143.
    PubMed     Abstract available

  232. LIU H, Bai Y, Zhang X, Gao T, et al
    SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
    J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
    PubMed     Abstract available

    May 2022
  233. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    J Virol. 2022 May 31:e0032022. doi: 10.1128/jvi.00320.
    PubMed     Abstract available

  234. ZHENG H, Ma L, Gui R, Lin X, et al
    G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2.
    J Virol. 2022 May 23:e0049422. doi: 10.1128/jvi.00494.
    PubMed     Abstract available

  235. VANDOORN E, Stadejek W, Parys A, Chepkwony S, et al
    Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
    J Virol. 2022 May 12:e0051922. doi: 10.1128/jvi.00519.
    PubMed     Abstract available

  236. NCHIOUA R, Schundner A, Kmiec D, Prelli Bozzo C, et al
    SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
    J Virol. 2022 May 11:e0059422. doi: 10.1128/jvi.00594.
    PubMed     Abstract available

    April 2022
  237. DIEFENBACHER M, Tan TJC, Bauer DLV, Stadtmueller BM, et al
    Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression.
    J Virol. 2022 Apr 25:e0020522. doi: 10.1128/jvi.00205.
    PubMed     Abstract available

  238. ROACH SN, Fiege JK, Shepherd FK, Wiggen TD, et al
    Respiratory Influenza Virus Infection Causes Dynamic Tuft Cell and Innate Lymphoid Cell Changes in the Small Intestine.
    J Virol. 2022 Apr 21:e0035222. doi: 10.1128/jvi.00352.
    PubMed     Abstract available

  239. KIRKPATRICK ROUBIDOUX E, Sano K, McMahon M, Carreno JM, et al
    Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
    J Virol. 2022 Apr 21:e0033222. doi: 10.1128/jvi.00332.
    PubMed     Abstract available

  240. ZHENG XS, Wang Q, Min J, Shen XR, et al
    Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
    J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
    PubMed     Abstract available

  241. RAJAN A, Piedra FA, Aideyan L, McBride T, et al
    Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection.
    J Virol. 2022;96:e0190421.
    PubMed     Abstract available

  242. NUNEZ CASTREJON AM, O'Rourke SM, Kauvar LM, DuBois RM, et al
    Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens.
    J Virol. 2022;96:e0220121.
    PubMed     Abstract available

  243. DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
    Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
    PubMed     Abstract available

  244. BAO D, Lu C, Ma T, Xu G, et al
    Hydrophobic Residues at the Intracellular Domain of the M2 Protein Play an Important Role in Budding and Membrane Integrity of Influenza Virus.
    J Virol. 2022 Apr 11:e0037322. doi: 10.1128/jvi.00373.
    PubMed     Abstract available

  245. CHEN J, Li Z, Guo J, Xu S, et al
    SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
    J Virol. 2022 Apr 7:e0003722. doi: 10.1128/jvi.00037.
    PubMed     Abstract available

  246. FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
    The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
    J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
    PubMed     Abstract available

  247. LI J, Lin C, Zhou X, Zhong F, et al
    Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
    J Virol. 2022 Apr 7:e0201321. doi: 10.1128/jvi.02013.
    PubMed     Abstract available

  248. KLASSE PJ, Moore JP
    Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
    J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
    PubMed     Abstract available

  249. LIU X, Zheng L, Wang T, Li Y, et al
    A System Based on Novel Parainfluenza Virus PIV5-L for Efficient Gene Delivery of B-Lymphoma Cells.
    J Virol. 2022 Apr 4:e0025722. doi: 10.1128/jvi.00257.
    PubMed     Abstract available

    March 2022
  250. HANCOCK TJ, Hickman P, Kazerooni N, Kennedy M, et al
    Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
    J Virol. 2022 Mar 30:e0025022. doi: 10.1128/jvi.00250.
    PubMed     Abstract available

  251. ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
    Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    J Virol. 2022 Mar 28:e0012822. doi: 10.1128/jvi.00128.
    PubMed     Abstract available

  252. GENG Q, Shi K, Ye G, Zhang W, et al
    Structural Basis for Human Receptor Recognition by SARS-CoV Omicron Variant BA.1.
    J Virol. 2022 Mar 28:e0024922. doi: 10.1128/jvi.00249.
    PubMed     Abstract available

  253. LIU MQ, Jiang RD, Guo J, Chen Y, et al
    Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
    PubMed     Abstract available

  254. XIANG J, Lu M, Shi M, Cheng X, et al
    Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
    PubMed     Abstract available

  255. JIANG L, Samant N, Liu P, Somasundaran M, et al
    Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
    J Virol. 2022;96:e0198221.
    PubMed     Abstract available

  256. LI Y, Liu S, Chen Y, Chen B, et al
    Syk Facilitates Influenza A Virus Replication by Restraining Innate Immunity at the Late Stage of Viral Infection.
    J Virol. 2022 Mar 16:e0020022. doi: 10.1128/jvi.00200.
    PubMed     Abstract available

  257. BERKHOUT B, Herrera-Carrillo E
    SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
    J Virol. 2022 Mar 16:e0009022. doi: 10.1128/jvi.00090.
    PubMed     Abstract available

  258. GAO J, Tang YD, Hu W, Zheng C, et al
    When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
    J Virol. 2022 Mar 16:e0013622. doi: 10.1128/jvi.00136.
    PubMed     Abstract available

  259. ALLEN JD, Ross TM
    Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
    J Virol. 2022 Mar 15:e0165221. doi: 10.1128/jvi.01652.
    PubMed     Abstract available

  260. METZ-ZUMARAN C, Kee C, Doldan P, Guo C, et al
    Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    J Virol. 2022 Mar 9:e0170521. doi: 10.1128/jvi.01705.
    PubMed     Abstract available

  261. HU M, Jones JC, Banoth B, Ojha CR, et al
    Swine H1N1 Influenza Virus Variants with Enhanced Polymerase Activity and HA Stability Promote Airborne Transmission in Ferrets.
    J Virol. 2022 Mar 7:e0010022. doi: 10.1128/jvi.00100.
    PubMed     Abstract available

    February 2022
  262. JUNG C, Kmiec D, Koepke L, Zech F, et al
    Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?
    J Virol. 2022 Feb 28:jvi0207721. doi: 10.1128/jvi.02077.
    PubMed     Abstract available

  263. KIM EH, Nguyen TQ, Casel MAB, Rollon R, et al
    Coinfection of SARS-CoV-2 and Influenza A virus increased disease severity, impaired neutralizing antibody, and CD4+ T cell responses.
    J Virol. 2022 Feb 2:jvi0187321. doi: 10.1128/jvi.01873.
    PubMed     Abstract available

  264. ROSU ME, Kok A, Bestebroer TM, de Meulder D, et al
    Contribution of neuraminidase to the efficacy of seasonal split influenza vaccines in the ferret model.
    J Virol. 2022 Feb 2:jvi0195921. doi: 10.1128/jvi.01959.
    PubMed     Abstract available

  265. ARIUMI Y
    Host cellular RNA helicases regulate SARS-CoV-2 infection.
    J Virol. 2022 Feb 2:jvi0000222. doi: 10.1128/jvi.00002.
    PubMed     Abstract available

    January 2022
  266. MURER L, Petkidis A, Vallet T, Vignuzzi M, et al
    Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
    J Virol. 2022;96:e0106021.
    PubMed     Abstract available

  267. LIU S, Chou CK, Wu WW, Luan B, et al
    Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    J Virol. 2022 Jan 26:jvi0221621. doi: 10.1128/jvi.02216.
    PubMed     Abstract available

  268. WONG TY, Horspool AM, Russ BP, Ye C, et al
    Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice.
    J Virol. 2022 Jan 26:jvi0218421. doi: 10.1128/jvi.02184.
    PubMed     Abstract available

  269. SPRUIT CM, Zhu X, Tomris I, Carrasco MR, et al
    N-glycolylneuraminic acid binding of avian and equine H7 influenza A viruses.
    J Virol. 2022 Jan 19:jvi0212021. doi: 10.1128/jvi.02120.
    PubMed     Abstract available

  270. BANERJEE S, De A, Kedia N, Bhakta K, et al
    The species-specific 282 residue in the PB2 subunit of the polymerase regulates RNA synthesis and replication of influenza A viruses infecting bat and non-bat hosts.
    J Virol. 2022 Jan 19:jvi0219021. doi: 10.1128/jvi.02190.
    PubMed     Abstract available

  271. MIYAMOTO S, Muramoto Y, Shindo K, Fujita-Fujiharu Y, et al
    Contribution of RNA-RNA interactions mediated by the genome packaging signals for the selective genome packaging of influenza A virus.
    J Virol. 2022 Jan 19:JVI0164121. doi: 10.1128/JVI.01641.
    PubMed     Abstract available

  272. DU S, Xu W, Wang Y, Li L, et al
    The "LLQY" motif on SARS-CoV-2 spike protein affects S incorporation into virus particles.
    J Virol. 2022 Jan 19:jvi0189721. doi: 10.1128/jvi.01897.
    PubMed     Abstract available

  273. TANG B, Sun EZ, Zhang ZL, Liu SL, et al
    Sphingomyelin-Sequestered Cholesterol Domain Recruits Formin-Binding Protein 17 for Constricting Clathrin-Coated Pits in Influenza Virus Entry.
    J Virol. 2022 Jan 12:JVI0181321. doi: 10.1128/JVI.01813.
    PubMed     Abstract available

  274. BHAT S, James J, Sadeyen JR, Mahmood S, et al
    Co-infection of chickens with H9N2 and H7N9 avian influenza viruses leads to emergence of reassortant H9N9 virus with increased fitness for poultry and a zoonotic potential.
    J Virol. 2022 Jan 12:jvi0185621. doi: 10.1128/jvi.01856.
    PubMed     Abstract available

  275. VELER H, Fan H, Keown J, Sharps J, et al
    The C-terminal domains of the PB2 subunit of the influenza A virus RNA polymerase directly interact with cellular GTPase Rab11a.
    J Virol. 2022 Jan 12:jvi0197921. doi: 10.1128/jvi.01979.
    PubMed     Abstract available

  276. RASHID MU, Gao A, Coombs KM
    Influenza A virus uses PSMA2 for downregulation of NRF2-mediated oxidative stress response.
    J Virol. 2022 Jan 12:jvi0199021. doi: 10.1128/jvi.01990.
    PubMed     Abstract available

  277. Articles of Significant Interest in This Issue.
    J Virol. 2022;96:e0186421.

  278. CHAUDHRY MZ, Eschke K, Hoffmann M, Grashoff M, et al
    Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    J Virol. 2022 Jan 12:jvi0218621. doi: 10.1128/jvi.02186.
    PubMed     Abstract available

  279. KIMBLE JB, Wymore Brand M, Kaplan BS, Gauger P, et al
    Vaccine-associated enhanced respiratory disease following influenza virus infection in ferrets recapitulates the model in pigs.
    J Virol. 2022 Jan 5:JVI0172521. doi: 10.1128/JVI.01725.
    PubMed     Abstract available

    December 2021
  280. HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
    SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
    J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
    PubMed     Abstract available

  281. NILSSON-PAYANT BE, tenOever BR, Te Velthuis AJW
    The host factor ANP32A is required for influenza A virus vRNA and cRNA synthesis.
    J Virol. 2021 Dec 22:jvi0209221. doi: 10.1128/jvi.02092.
    PubMed     Abstract available

  282. OLIVARRIA GM, Cheng Y, Furman S, Pachow C, et al
    Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
    J Virol. 2021 Dec 22:jvi0196921. doi: 10.1128/jvi.01969.
    PubMed     Abstract available

  283. ETTICH J, Werner J, Weitz HT, Mueller E, et al
    A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
    J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
    PubMed     Abstract available

  284. GUO J, Chen J, Li Y, Li Y, et al
    SUMOylation of matrix protein M1 and filamentous morphology collectively contribute to the replication and virulence of highly pathogenic H5N1 avian influenza viruses in mammals.
    J Virol. 2021 Dec 15:JVI0163021. doi: 10.1128/JVI.01630.
    PubMed     Abstract available

  285. CAO K, Wang X, Peng H, Ding L, et al
    A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
    J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
    PubMed     Abstract available

  286. NELSON M, O'Brien LM, Davies C, Keyser E, et al
    Comparison of experimental MERS-CoV infection acquired by three individual routes of infection in the common marmoset.
    J Virol. 2021 Dec 15:JVI0173921. doi: 10.1128/JVI.01739.
    PubMed     Abstract available

  287. SAKA N, Matsumoto Y, Ohta K, Kolakofsky D, et al
    A point mutation in human parainfluenza virus type 2 nucleoprotein leads to two separate effects on virus replication.
    J Virol. 2021 Dec 8:JVI0206721. doi: 10.1128/JVI.02067.
    PubMed     Abstract available

  288. ZHANG Y, Yan Q, Luo K, He P, et al
    Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection.
    J Virol. 2021 Dec 8:JVI0160021. doi: 10.1128/JVI.01600.
    PubMed     Abstract available

  289. MALICOAT J, Manivasagam S, Zuniga S, Sola I, et al
    Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories.
    J Virol. 2021 Dec 1:JVI0183721. doi: 10.1128/JVI.01837.
    PubMed     Abstract available

    November 2021
  290. ZHANG S, Go EP, Ding H, Anang S, et al
    Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
    J Virol. 2021 Nov 24:JVI0162621. doi: 10.1128/JVI.01626.
    PubMed     Abstract available

  291. MARTINS M, Fernandes MHV, Joshi LR, Diel DG, et al
    Age-related susceptibility of ferrets to SARS-CoV-2 infection.
    J Virol. 2021 Nov 24:JVI0145521. doi: 10.1128/JVI.01455.
    PubMed     Abstract available

  292. BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
    Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
    PubMed     Abstract available

  293. TAKAMATSU Y, Imai M, Maeda K, Nakajima N, et al
    Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
    J Virol. 2021 Nov 24:JVI0155121. doi: 10.1128/JVI.01551.
    PubMed     Abstract available

  294. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.

  295. LIU Y, Wang B, Liang QZ, Shi FS, et al
    Roles of Two Major Domains of the Porcine Deltacoronavirus S1 Subunit in Receptor Binding and Neutralization.
    J Virol. 2021;95:e0111821.
    PubMed     Abstract available

  296. DANIELS RS, Galiano M, Ermetal B, Kwong J, et al
    Temporal and gene reassortment analysis of influenza C outbreaks in Hong Kong SAR, China.
    J Virol. 2021 Nov 17:JVI0192821. doi: 10.1128/JVI.01928.
    PubMed     Abstract available

  297. CHAI H, Li X, Li M, Lv X, et al
    Emergence, Evolution, and Pathogenicity of Influenza A(H7N4) Virus in Shorebirds, China.
    J Virol. 2021 Nov 17:JVI0171721. doi: 10.1128/JVI.01717.
    PubMed     Abstract available

  298. SOUZA CK, Anderson TK, Chang J, Venkatesh D, et al
    Antigenic distance between North American swine and human seasonal H3N2 influenza A viruses as an indication of zoonotic risk to humans.
    J Virol. 2021 Nov 10:JVI0137421. doi: 10.1128/JVI.01374.
    PubMed     Abstract available

  299. BASU A, Penumutchu S, Nguyen K, Mbonye U, et al
    A structurally conserved RNA element within SARS-CoV-2 ORF1a RNA and S mRNA regulates translation in response to viral S protein-induced signaling in human lung cells.
    J Virol. 2021 Nov 10:JVI0167821. doi: 10.1128/JVI.01678.
    PubMed     Abstract available

  300. DONG X, Wang X, Xie M, Wu W, et al
    Structural Basis of Human Parainfluenza Virus 3 Unassembled Nucleoprotein in Complex with Its Viral ChaperoneHPIV3 Nucleoprotein-Phosphoprotein Structure.
    J Virol. 2021 Nov 3:JVI0164821. doi: 10.1128/JVI.01648.
    PubMed     Abstract available

  301. LAMARCA AP, de Almeida LGP, da Silva Francisco Junior R, Cavalcante L, et al
    Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil.
    J Virol. 2021 Nov 3:JVI0122821. doi: 10.1128/JVI.01228.
    PubMed     Abstract available

    October 2021
  302. DESCAMPS D, Peres de Oliveira A, Gonnin L, Madrieres S, et al
    Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
    J Virol. 2021;95:e0091221.
    PubMed     Abstract available

  303. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Reply to Grigoriev et al., "Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs 1 of Non-coding RNA?"
    J Virol. 2021 Oct 27:JVI0169021. doi: 10.1128/JVI.01690.
    PubMed     Abstract available

  304. YU J, Collins ND, Mercado NB, McMahan K, et al
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
    PubMed     Abstract available

  305. GRIGORIEV A, Kelley JJ, Guan L
    Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs of Non-coding RNA?
    J Virol. 2021 Oct 27:JVI0146221. doi: 10.1128/JVI.01462.
    PubMed     Abstract available

  306. TAN J, O'Dell G, Hernandez MM, Sordillo EM, et al
    Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model.
    J Virol. 2021 Oct 20:JVI0142121. doi: 10.1128/JVI.01421.
    PubMed     Abstract available

  307. WINKLER ES, Chen RE, Alam F, Yildiz S, et al
    SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice.
    J Virol. 2021 Oct 20:JVI0151121. doi: 10.1128/JVI.01511.
    PubMed     Abstract available

  308. DONG W, Mead H, Tian L, Park JG, et al
    The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
    J Virol. 2021 Oct 20:JVI0096421. doi: 10.1128/JVI.00964.
    PubMed     Abstract available

  309. REN W, Zhu Y, Lan J, Chen H, et al
    Susceptibilities of human ACE2 genetic variants in coronavirus infection.
    J Virol. 2021 Oct 20:JVI0149221. doi: 10.1128/JVI.01492.
    PubMed     Abstract available

  310. SIDDIQ MM, Chan AT, Miorin L, Yadaw AS, et al
    Functional Effects of Cardiomyocyte Injury in COVID-19.
    J Virol. 2021 Oct 20:JVI0106321. doi: 10.1128/JVI.01063.
    PubMed     Abstract available

  311. GAO Q, Yang C, Ren C, Zhang S, et al
    Correction for Gao et al., "Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus".
    J Virol. 2021;95:e0141321.

  312. GAO J, Klenow L, Parsons L, Malik T, et al
    Design of the Recombinant Influenza Neuraminidase Antigen is Crucial for its Biochemical Properties and Protective Efficacy.
    J Virol. 2021 Oct 6:JVI0116021. doi: 10.1128/JVI.01160.
    PubMed     Abstract available

  313. BESSIERE P, Figueroa T, Coggon A, Foret-Lucas C, et al
    Opposite outcomes of the within-host competition between highly and low pathogenic H5N8 avian influenza viruses in chickens compared to ducks.
    J Virol. 2021 Oct 6:JVI0136621. doi: 10.1128/JVI.01366.
    PubMed     Abstract available

  314. NAVARATNARAJAH CK, Pease DR, Halfmann P, Taye B, et al
    Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.
    J Virol. 2021 Oct 6:JVI0136821. doi: 10.1128/JVI.01368.
    PubMed     Abstract available

    September 2021
  315. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    PubMed     Abstract available

  316. SHUE B, Chiramel AI, Cerikan B, To TH, et al
    Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication.
    J Virol. 2021 Sep 29:JVI0059621. doi: 10.1128/JVI.00596.
    PubMed     Abstract available

  317. KIM YJ, Witwit H, Cubitt B, de la Torre JC, et al
    Inhibitors of anti-apoptotic Bcl-2 family proteins exhibit potent and broad-spectrum anti-mammarenavirus activity via cell cycle arrest at G0/G1 phase.
    J Virol. 2021 Sep 29:JVI0139921. doi: 10.1128/JVI.01399.
    PubMed     Abstract available

  318. TANG W, Li Y, Song Q, Wang Z, et al
    Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.
    J Virol. 2021;95:e0120521.
    PubMed     Abstract available

  319. PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
    Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
    J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
    PubMed     Abstract available

  320. QIAN Y, Lei T, Patel PS, Lee CH, et al
    Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
    J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
    PubMed     Abstract available

  321. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    PubMed     Abstract available

  322. ACHARYA A, Pandey K, Thurman M, Klug E, et al
    Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants.
    J Virol. 2021 Sep 22:JVI0143721. doi: 10.1128/JVI.01437.
    PubMed     Abstract available

  323. SHANG C, Zhuang X, Zhang H, Li Y, et al
    Inhibition of autophagy suppresses SARS-CoV-2 replication and ameliorates pneumonia in hACE2 transgenic mice and xenografted human lung tissues.
    J Virol. 2021 Sep 22:JVI0153721. doi: 10.1128/JVI.01537.
    PubMed     Abstract available

  324. KIRCHENBAUM GA, Sautto GA, Richardson RA, Ecker JW, et al
    A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus.
    J Virol. 2021 Sep 15:JVI0237920. doi: 10.1128/JVI.02379.
    PubMed     Abstract available

  325. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    PubMed     Abstract available

  326. NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
    The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
    J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
    PubMed     Abstract available

  327. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    PubMed     Abstract available

  328. ABRAHAM M, Beavis AC, Xiao P, Villinger FJ, et al
    Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus (JPV)-expressing HA of influenza A virus H5N1.
    J Virol. 2021 Sep 1:JVI0132121. doi: 10.1128/JVI.01321.
    PubMed     Abstract available

  329. WILLIAMS CM, Roy S, Califano D, McKenzie ANJ, et al
    IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine.
    J Virol. 2021 Sep 1:JVI0059821. doi: 10.1128/JVI.00598.
    PubMed     Abstract available

    August 2021
  330. XUN G, Song X, Hu J, Zhang H, et al
    Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
    J Virol. 2021;95:e0048521.
    PubMed     Abstract available

  331. SATO K, Hayashi H, Shimotai Y, Yamaya M, et al
    TMPRSS2 activates hemagglutinin-esterase glycoprotein of influenza C virus.
    J Virol. 2021 Aug 18:JVI0129621. doi: 10.1128/JVI.01296.
    PubMed     Abstract available

  332. KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
    Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
    PubMed     Abstract available

  333. KAPLAN BS, Anderson TK, Chang J, Santos J, et al
    Evolution and antigenic advancement of N2 neuraminidase of swine influenza A viruses circulating in the United States following two separate introductions from human seasonal viruses.
    J Virol. 2021 Aug 11:JVI0063221. doi: 10.1128/JVI.00632.
    PubMed     Abstract available

  334. KAWAI A, Yamamoto Y, Nogimori T, Takeshita K, et al
    The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses.
    J Virol. 2021 Aug 11:JVI0118021. doi: 10.1128/JVI.01180.
    PubMed     Abstract available

  335. TAM EH, Liu YC, Woung CH, Liu HM, et al
    Role of the chaperone protein 14-3-3epsilon in the regulation of influenza A virus-activated beta interferon.
    J Virol. 2021 Aug 11:JVI0023121. doi: 10.1128/JVI.00231.
    PubMed     Abstract available

  336. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    PubMed     Abstract available

    July 2021
  337. DEL SARTO J, Gerlt V, Friedrich ME, Anhlan D, et al
    Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection.
    J Virol. 2021 Jul 28:JVI0067221. doi: 10.1128/JVI.00672.
    PubMed     Abstract available

  338. BESTLE D, Limburg H, Kruhl D, Harbig A, et al
    Hemagglutinins of avian influenza viruses are proteolytically activated by TMPRSS2 in human and murine airway cells.
    J Virol. 2021 Jul 28:JVI0090621. doi: 10.1128/JVI.00906.
    PubMed     Abstract available

  339. CANTWELL AM, Singh H, Platt M, Yu Y, et al
    Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
    J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
    PubMed     Abstract available

  340. RAHMAN K, Compton AA
    The indirect antiviral potential of long non-coding RNAs encoded by IFITM pseudogenes.
    J Virol. 2021 Jul 28:JVI0068021. doi: 10.1128/JVI.00680.
    PubMed     Abstract available

  341. GREEN G, Johnson SM, Costello H, Brakel K, et al
    CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
    J Virol. 2021;95:e0001021.
    PubMed     Abstract available

  342. YANG J, Zhang P, Huang M, Qiao S, et al
    Key amino acids of M1-41 and M2-27 determine growth and pathogenicity of chimeric H17 bat influenza virus in cells and in mice.
    J Virol. 2021 Jul 21:JVI0101921. doi: 10.1128/JVI.01019.
    PubMed     Abstract available

  343. LI Z, Gao F, Lan Y, Guan J, et al
    Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
    J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
    PubMed     Abstract available

  344. FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
    J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
    PubMed     Abstract available

  345. CHEN DY, Khan N, Close BJ, Goel RK, et al
    SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
    J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
    PubMed     Abstract available

  346. LAI KK, Cheung NN, Yang F, Dai J, et al
    Correction for Lai et al., "Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics".
    J Virol. 2021;95:e0066521.

  347. LIANG W, Zhang Y, Li M, Al-Shaebi F, et al
    Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.
    J Virol. 2021;95:e0056321.
    PubMed     Abstract available

  348. LEYSON CM, Youk S, Ferreira HL, Suarez DL, et al
    Multiple gene segments are associated with enhanced virulence of clade H5N8 highly pathogenic avian influenza virus in mallards.
    J Virol. 2021 Jul 7:JVI0095521. doi: 10.1128/JVI.00955.
    PubMed     Abstract available

    June 2021
  349. YU J, Huang C, Sheng Z, Wang Z, et al
    Identification of One Critical Amino Acid Residue of the Nucleoprotein as a Determinant for in vitro Viral Replication Fitness of Influenza D Virus.
    J Virol. 2021 Jun 30:JVI0097121. doi: 10.1128/JVI.00971.
    PubMed     Abstract available

  350. XIAO Y, Zhang W, Pan M, Bauer DLV, et al
    A synergistic effect between 3' terminal noncoding and adjacent coding regions of influenza A virus HA segment on template preference.
    J Virol. 2021 Jun 30:JVI0087821. doi: 10.1128/JVI.00878.
    PubMed     Abstract available

  351. NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
    Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
    J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
    PubMed     Abstract available

  352. BLAUROCK C, Breithaupt A, Scheibner D, Bagato O, et al
    Preferential selection and contribution of non-structural protein 1 (NS1) to the efficient transmission of the panzootic avian influenza H5N8 clades A and B viruses in chickens and ducks.
    J Virol. 2021 Jun 23:JVI0044521. doi: 10.1128/JVI.00445.
    PubMed     Abstract available

  353. SKARLUPKA AL, Bebin-Blackwell AG, Sumner SF, Ross TM, et al
    Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains.
    J Virol. 2021 Jun 23:JVI0075921. doi: 10.1128/JVI.00759.
    PubMed     Abstract available

  354. SUN G, Sui Y, Zhou Y, Ya J, et al
    Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
    J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
    PubMed     Abstract available

  355. KUMAR A, Ishida R, Strilets T, Cole J, et al
    SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    J Virol. 2021;95:e0026621.
    PubMed     Abstract available

  356. WANG X, Zhao Y, Yan F, Wang T, et al
    Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
    J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
    PubMed     Abstract available

  357. NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
    Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
    J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
    PubMed     Abstract available

  358. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    PubMed     Abstract available

    May 2021
  359. LIU H, Plancarte M, Ball EE, Weiss CM, et al
    Respiratory tract explant infection dynamics of influenza A virus in California sea lions, northern elephant seals, and rhesus macaques.
    J Virol. 2021 May 26:JVI0040321. doi: 10.1128/JVI.00403.
    PubMed     Abstract available

  360. BAKRE A, Jones L, Murray J, Reneer ZB, et al
    Innate antiviral cytokine response to swine influenza virus by swine respiratory epithelial cells.
    J Virol. 2021 May 12. pii: JVI.00692-21. doi: 10.1128/JVI.00692.
    PubMed     Abstract available

  361. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
    J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
    PubMed     Abstract available

  362. LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
    Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
    J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
    PubMed     Abstract available

  363. TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
    ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
    J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
    PubMed     Abstract available

  364. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    PubMed     Abstract available

  365. HORMAN WSJ, Kedzierska K, Rootes CL, Bean AGD, et al
    Upregulated expression of ferret Interferon-Inducible Transmembrane genes by IFN-alpha and influenza virus infection.
    J Virol. 2021 May 5. pii: JVI.00111-21. doi: 10.1128/JVI.00111.
    PubMed     Abstract available

    April 2021
  366. RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
    Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
    J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
    PubMed     Abstract available

  367. ALFI O, Yakirevitch A, Wald O, Wandel O, et al
    Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
    J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
    PubMed     Abstract available

  368. VIDAL SJ, Collier AY, Yu J, McMahan K, et al
    Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
    J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
    PubMed     Abstract available

  369. SAUTTO GA, Ecker JW, Ross TM
    An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus.
    J Virol. 2021 Apr 14. pii: JVI.02421-20. doi: 10.1128/JVI.02421.
    PubMed     Abstract available

  370. CHIEM K, Lopez-Garcia D, Ortego J, Martinez-Sobrido L, et al
    Identification of amino acid residues required for inhibition of host gene expression by influenza A/Viet Nam/1203/2004 H5N1 PA-X.
    J Virol. 2021 Apr 14. pii: JVI.00408-21. doi: 10.1128/JVI.00408.
    PubMed     Abstract available

  371. NILSSON-PAYANT BE, Blanco-Melo D, Uhl S, Escudero-Perez B, et al
    Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
    J Virol. 2021;95.
    PubMed     Abstract available

  372. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    PubMed     Abstract available

  373. ZHENG J, Wen L, Yen HL, Liu M, et al
    Phenotypic and functional characteristics of a novel influenza hemagglutinin-specific memory NK cell.
    J Virol. 2021 Apr 7. pii: JVI.00165-21. doi: 10.1128/JVI.00165.
    PubMed     Abstract available

  374. ZHANG H, Zheng H, Guo P, Hu L, et al
    Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine.
    J Virol. 2021 Apr 7. pii: JVI.00507-21. doi: 10.1128/JVI.00507.
    PubMed     Abstract available

  375. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    PubMed     Abstract available

    March 2021
  376. WANG J, Shu T, Deng W, Zheng Y, et al
    Mucosal priming with a recombinant influenza A virus-vectored vaccine elicits T-cell and antibody responses to HIV-1 in mice.
    J Virol. 2021 Mar 31. pii: JVI.00059-21. doi: 10.1128/JVI.00059.
    PubMed     Abstract available

  377. LIU W, Reyes HM, Yang JF, Li Y, et al
    Activation of STING signaling pathway effectively blocks human coronavirus infection.
    J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
    PubMed     Abstract available

  378. TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
    The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
    J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
    PubMed     Abstract available

  379. SLAINE PD, Kleer M, Duguay BA, Pringle ES, et al
    Thiopurines activate an antiviral unfolded protein response that blocks influenza A virus glycoprotein accumulation.
    J Virol. 2021 Mar 24. pii: JVI.00453-21. doi: 10.1128/JVI.00453.
    PubMed     Abstract available

  380. DANZY S, Lowen AC, Steel J
    A quantitative approach to assess influenza A virus fitness and transmission in guinea pigs.
    J Virol. 2021 Mar 17. pii: JVI.02320-20. doi: 10.1128/JVI.02320.
    PubMed     Abstract available

  381. PU J, Yin Y, Liu J, Wang X, et al
    Reassortment with dominant chicken H9N2 influenza virus contributed to the fifth H7N9 virus human epidemic.
    J Virol. 2021 Mar 17. pii: JVI.01578-20. doi: 10.1128/JVI.01578.
    PubMed     Abstract available

  382. YANG H, Winkler W, Wu X
    Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1.
    J Virol. 2021 Mar 10. pii: JVI.00283-21. doi: 10.1128/JVI.00283.
    PubMed     Abstract available

  383. PENG J, Ran Y, Xie H, Deng L, et al
    Sarco/Endoplasmic Reticulum Ca(2+) Transporting ATPase (SERCA) Modulates Autophagic, Inflammatory, and Mitochondrial Responses during Influenza A Virus Infection in Human Lung Cells.
    J Virol. 2021 Mar 10. pii: JVI.00217-21. doi: 10.1128/JVI.00217.
    PubMed     Abstract available

  384. GONG W, He X, Huang K, Zhang Y, et al
    Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly.
    J Virol. 2021 Mar 3. pii: JVI.00008-21. doi: 10.1128/JVI.00008.
    PubMed     Abstract available

  385. PHAN T, Fay EJ, Lee Z, Aron S, et al
    Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.
    J Virol. 2021 Mar 3. pii: JVI.02102-20. doi: 10.1128/JVI.02102.
    PubMed     Abstract available

  386. LUO Z, Girton AW, Heaton BE, Heaton NS, et al
    Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.
    J Virol. 2021 Mar 3. pii: JVI.02021-20. doi: 10.1128/JVI.02021.
    PubMed     Abstract available

    February 2021
  387. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    Correction for Jeong et al., "In Vitro Profiling of Laninamivir-Resistant Substitutions in N3 to N9 Avian Influenza Virus Neuraminidase Subtypes and Their Association with In Vivo Susceptibility".
    J Virol. 2021;95.

  388. YANG F, Pang B, Lai KK, Cheung NN, et al
    Discovery of a novel specific inhibitor targeting influenza A nucleoprotein with pleiotropic inhibitory effects on various steps of viral life cycle.
    J Virol. 2021 Feb 24. pii: JVI.01432-20. doi: 10.1128/JVI.01432.
    PubMed     Abstract available

  389. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    PubMed     Abstract available

  390. HOYE BJ, Donato CM, Lisovski S, Deng YM, et al
    Reassortment and persistence of influenza A viruses from diverse geographic origins within Australian wild birds: evidence from a small, isolated population of Ruddy turnstones.
    J Virol. 2021 Feb 24. pii: JVI.02193-20. doi: 10.1128/JVI.02193.
    PubMed     Abstract available

  391. BINJAWADAGI B, Ma Y, Binjawadagi R, Brakel K, et al
    Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    J Virol. 2021;95.
    PubMed     Abstract available

  392. HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
    SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
    J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
    PubMed     Abstract available

  393. ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
    GPCR and ion channel genes used by influenza virus for replication.
    J Virol. 2021 Feb 3. pii: JVI.02410-20. doi: 10.1128/JVI.02410.
    PubMed     Abstract available

    January 2021
  394. LEVENE RE, Shrestha SD, Gaglia MM
    The influenza A virus host shutoff factor PA-X is rapidly turned over in a strain-specific manner.
    J Virol. 2021 Jan 27. pii: JVI.02312-20. doi: 10.1128/JVI.02312.
    PubMed     Abstract available

  395. ZHANG X, Pu J, Sun Y, Yuhai B, et al
    Neurovirulence of avian influenza virus is dependent on the interaction of viral NP protein with host factor FMRP in the murine brain.
    J Virol. 2021 Jan 6. pii: JVI.01272-20. doi: 10.1128/JVI.01272.
    PubMed     Abstract available

  396. PATIL A, Anhlan D, Ferrando V, Mecate-Zambrano A, et al
    Phosphorylation of influenza A virus NS1 at serine 205 mediates its viral polymerase-enhancing function.
    J Virol. 2021 Jan 6. pii: JVI.02369-20. doi: 10.1128/JVI.02369.
    PubMed     Abstract available

  397. FENG M, Zhang Q, Wu W, Chen L, et al
    Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-kappaB and JAK-STAT Signaling Pathways.
    J Virol. 2021 Jan 6. pii: JVI.02038-20. doi: 10.1128/JVI.02038.
    PubMed     Abstract available

  398. OHTA K, Saka N, Nishio M
    Human parainfluenza virus type 2 V protein modulates iron homeostasis.
    J Virol. 2021 Jan 6. pii: JVI.01861-20. doi: 10.1128/JVI.01861.
    PubMed     Abstract available

    December 2020
  399. WANG Q, Pan W, Wang S, Pan C, et al
    Protein tyrosine phosphatase SHP2 suppresses host innate immunity against influenza A virus through regulating EGFR-mediated signaling.
    J Virol. 2020 Dec 23. pii: JVI.02001-20. doi: 10.1128/JVI.02001.
    PubMed     Abstract available

  400. VERHAGEN JH, Eriksson P, Leijten L, Blixt O, et al
    Host range of influenza A virus H1 to H16 in Eurasian ducks based on tissue and receptor binding studies.
    J Virol. 2020 Dec 23. pii: JVI.01873-20. doi: 10.1128/JVI.01873.
    PubMed     Abstract available

  401. HUMAN S, Hotard AL, Rostad CA, Lee S, et al
    A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    J Virol. 2020;95.
    PubMed     Abstract available

  402. LEE E, Sandgren K, Duette G, Stylianou VV, et al
    Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
    J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
    PubMed     Abstract available

  403. YOUK SS, Leyson CM, Seibert BA, Jadhao S, et al
    Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade in Chickens.
    J Virol. 2020 Dec 2. pii: JVI.01675-20. doi: 10.1128/JVI.01675.
    PubMed     Abstract available

  404. BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
    Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
    J Virol. 2020 Dec 2. pii: JVI.01027-20. doi: 10.1128/JVI.01027.
    PubMed     Abstract available

  405. EVERETT HE, van Diemen PM, Aramouni M, Ramsay A, et al
    Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs.
    J Virol. 2020 Dec 2. pii: JVI.01787-20. doi: 10.1128/JVI.01787.
    PubMed     Abstract available

  406. PEACOCK TP, Sealy JE, Harvey WT, Benton DJ, et al
    Genetic determinants of receptor-binding preference and zoonotic potential of H9N2 avian influenza viruses.
    J Virol. 2020 Dec 2. pii: JVI.01651-20. doi: 10.1128/JVI.01651.
    PubMed     Abstract available

    November 2020
  407. PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
    A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
    PubMed     Abstract available

  408. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    PubMed     Abstract available

  409. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    PubMed     Abstract available

  410. MA N, Li X, Jiang H, Dai Y, et al
    Influenza neuraminidase engages CD83 and promotes pulmonary injury.
    J Virol. 2020 Nov 11. pii: JVI.01753-20. doi: 10.1128/JVI.01753.
    PubMed     Abstract available

  411. BAO D, Xue R, Zhang M, Lu C, et al
    N-linked glycosylation plays an important role in budding of NA protein and virulence of influenza viruses.
    J Virol. 2020 Nov 11. pii: JVI.02042-20. doi: 10.1128/JVI.02042.
    PubMed     Abstract available

  412. TIAN X, Landreth S, Lu Y, Pandey K, et al
    A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    J Virol. 2020 Nov 11. pii: JVI.02154-20. doi: 10.1128/JVI.02154.
    PubMed     Abstract available

  413. JENKINS T, Wang R, Harder O, Xue M, et al
    A novel live attenuated RSV vaccine candidate with mutations in the L protein SAM binding site and the G protein cleavage site is protective in cotton rats and a rhesus macaque.
    J Virol. 2020 Nov 11. pii: JVI.01568-20. doi: 10.1128/JVI.01568.
    PubMed     Abstract available

  414. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    PubMed     Abstract available

    October 2020
  415. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    PubMed     Abstract available

  416. LIANG B, Matsuoka Y, Le Nouen C, Liu X, et al
    A parainfluenza virus vector expressing the respiratory syncytial virus (RSV) prefusion F protein is more effective than RSV for boosting a primary immunization with RSV.
    J Virol. 2020 Oct 28. pii: JVI.01512-20. doi: 10.1128/JVI.01512.
    PubMed     Abstract available

  417. GHORBANI A, Abundo MC, Ji H, Taylor KJM, et al
    Viral Subpopulation Screening Guides in Designing a High Interferon Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    J Virol. 2020 Oct 28. pii: JVI.01722-20. doi: 10.1128/JVI.01722.
    PubMed     Abstract available

  418. COOK PW, Stark T, Jones J, Kondor R, et al
    Detection and Characterization of Swine-origin Influenza A(H1N1) Pandemic 2009 Viruses in Humans Following Zoonotic Transmission.
    J Virol. 2020 Oct 28. pii: JVI.01066-20. doi: 10.1128/JVI.01066.
    PubMed     Abstract available

  419. RENEER ZB, Jamieson PJ, Skarlupka AL, Huang Y, et al
    Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    J Virol. 2020 Oct 28. pii: JVI.01526-20. doi: 10.1128/JVI.01526.
    PubMed     Abstract available

  420. JOBE F, Simpson J, Hawes P, Guzman E, et al
    Respiratory Syncytial Virus Sequesters NF-kappaB Subunit p65 to Cytoplasmic Inclusion Bodies To Inhibit Innate Immune Signaling.
    J Virol. 2020;94.
    PubMed     Abstract available

  421. GAO Q, Yang C, Ren C, Zhang S, et al
    Eukaryotic translation elongation factor 1 delta inhibits the nuclear import of nucleoprotein and PA-PB1 heterodimer of influenza A virus.
    J Virol. 2020 Oct 21. pii: JVI.01391-20. doi: 10.1128/JVI.01391.
    PubMed     Abstract available

  422. MANZOOR R, Eguchi N, Yoshida R, Ozaki H, et al
    A novel mechanism underlying antiviral activity of an influenza virus M2-specific antibody.
    J Virol. 2020 Oct 14. pii: JVI.01277-20. doi: 10.1128/JVI.01277.
    PubMed     Abstract available

  423. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    In vitro profiling of laninamivir-resistant substitutions in N3 to N9 avian influenza neuraminidase subtypes and their association with in vivo susceptibility.
    J Virol. 2020 Oct 14. pii: JVI.01679-20. doi: 10.1128/JVI.01679.
    PubMed     Abstract available

  424. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    PubMed     Abstract available

  425. LI Z, Qu X, Liu X, Huan C, et al
    GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    PubMed     Abstract available

  426. ARAI Y, Kawashita N, Elgendy EM, Ibrahim MS, et al
    PA mutations inherited during viral evolution act cooperatively to increase replication of contemporary H5N1 influenza virus with an expanded host range.
    J Virol. 2020 Oct 7. pii: JVI.01582-20. doi: 10.1128/JVI.01582.
    PubMed     Abstract available

  427. WEI Y, Zeng Y, Zhang X, Xu S, et al
    The Nucleoprotein of H7N9 Influenza Virus Positively Regulates TRAF3-Mediated Innate Signaling and Attenuates Viral Virulence in Mice.
    J Virol. 2020 Oct 7. pii: JVI.01640-20. doi: 10.1128/JVI.01640.
    PubMed     Abstract available

    September 2020
  428. CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
    Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
    J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
    PubMed     Abstract available

  429. NELSON MI, Perofsky A, McBride DS, Rambo-Martin BL, et al
    A heterogenous swine show circuit drives zoonotic transmission of influenza A viruses in the United States.
    J Virol. 2020 Sep 30. pii: JVI.01453-20. doi: 10.1128/JVI.01453.
    PubMed     Abstract available

  430. XUE M, Wang R, Harder O, Chen P, et al
    Stable attenuation of human respiratory syncytial virus for live vaccines by deletion and insertion of amino acids in the hinge region between the mRNA capping and methyltransferase domains of the large polymerase protein.
    J Virol. 2020 Sep 30. pii: JVI.01831-20. doi: 10.1128/JVI.01831.
    PubMed     Abstract available

  431. KINDER JT, Moncman CL, Barrett C, Jin H, et al
    Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
    J Virol. 2020;94.
    PubMed     Abstract available

  432. BROCATO RL, Principe LM, Kim RK, Zeng X, et al
    Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
    J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
    PubMed     Abstract available

    August 2020
  433. BUSSE DC, Habgood-Coote D, Clare S, Brandt C, et al
    Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    PubMed     Abstract available

  434. FROGGATT HM, Heaton BE, Heaton NS
    Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
    J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
    PubMed     Abstract available

  435. WESTON S, Coleman CM, Haupt R, Logue J, et al
    Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
    J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
    PubMed     Abstract available

  436. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    PubMed     Abstract available

    July 2020
  437. KAPLAN BS, Kimble JB, Chang J, Anderson TK, et al
    Aerosol Transmission from Infected Swine to Ferrets of an H3N2 Virus Collected from an Agricultural Fair and Associated with Human Variant Infections.
    J Virol. 2020;94.
    PubMed     Abstract available

  438. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    PubMed     Abstract available

    June 2020
  439. GHAFARI M, Lumby CK, Weissman DB, Illingworth CJR, et al
    Inferring Transmission Bottleneck Size from Viral Sequence Data Using a Novel Haplotype Reconstruction Method.
    J Virol. 2020;94.
    PubMed     Abstract available

  440. DENG Y, Herbert JA, Robinson E, Ren L, et al
    Neutrophil-Airway Epithelial Interactions Result in Increased Epithelial Damage and Viral Clearance during Respiratory Syncytial Virus Infection.
    J Virol. 2020;94.
    PubMed     Abstract available

    May 2020
  441. LI J, Li M, Wang X, Sun M, et al
    Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
    J Virol. 2020;94.
    PubMed     Abstract available

    April 2020
  442. YANG J, Ma C, Zhao Y, Fan A, et al
    Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology.
    J Virol. 2020 Apr 22. pii: JVI.00007-20. doi: 10.1128/JVI.00007.
    PubMed     Abstract available

  443. KANDASAMY M, Furlong K, Perez JT, Manicassamy S, et al
    Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
    J Virol. 2020;94.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.